| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.38 | 2e-17 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.27 | 6e-09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.063 | 0.1 |